Dr. Cadegiani is a leading expert in Endocrinology, Sports Medicine, and Obesity Management. A core contributor to the FLCCC COVID-19 protocols, Dr. Cadegiani has successfully treated thousands of COVID patients in Brazil with few hospitalizations and no deaths.

Regarding COVID-19, Dr. Cadegiani conducted some of the largest clinical trials and observational studies, including the Itajaí ivermectin studies. He is responsible for the first hypothesis that explains the massive number of post-vaccine myocarditis cases and sudden deaths, particularly among young males and athletes.
After attaining his medical degree from the University of Brasilia in 2008, Dr. Cadegiani completed a residency in internal medicine in 2010 and a fellowship in Endocrinology and Metabolism in 2012.

He has conducted extensive research on fatigue-related conditions, ‘hormonal conditioning’, and pharmacological weight loss management, and is the creator of the first scientifically proven effective therapy to prevent bariatric surgery in morbidly obese subjects.

Join the Ken & Eric of the GCP as Dr. Cardegiani describes how his efforts to save lives led to political
firestorms while speaking at the FLCCC educational conference 2023.

Twitter
@FlavioCadegiani

https://www.cureus.com/users/213984-flavio-a-cadegiani

FLCCC 2023 Educational Series & Lectures

https://covid19criticalcare.com/courses/conference-2023-spring-basic/

Please LIKE & SHARE and use code “HERO” for a free month of GCP RAW!

If you ever want to ask a question for upcoming guests, just click here and give GCP RAW a try on us:

https://gutcheckproject.locals.com/support/promo/HERO